Related Experiment Video

Updated: Feb 14, 2026

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
07:05

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: February 23, 2024

3.8K

Reply to Masin et al: To be or not to be a phospholipase A

Helena Ostolaza1,2

  • 1Biofisika Institute (UPV/EHU, CSIC), University of Basque Country, 48080 Bilbao, Spain; elenaamaya.ostolaza@ehu.es.

Proceedings of the National Academy of Sciences of the United States of America
|February 23, 2018
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Defining Substrate Specificities for Lipase and Phospholipase Candidates
08:59

Defining Substrate Specificities for Lipase and Phospholipase Candidates

Published on: November 23, 2016

15.6K
Author Spotlight: Optimization of Performance Parameters of the TAGGG Telomere Length Assay
08:23

Author Spotlight: Optimization of Performance Parameters of the TAGGG Telomere Length Assay

Published on: April 21, 2023

3.7K

Related Experiment Videos

Last Updated: Feb 14, 2026

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
07:05

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: February 23, 2024

3.8K
Defining Substrate Specificities for Lipase and Phospholipase Candidates
08:59

Defining Substrate Specificities for Lipase and Phospholipase Candidates

Published on: November 23, 2016

15.6K
Author Spotlight: Optimization of Performance Parameters of the TAGGG Telomere Length Assay
08:23

Author Spotlight: Optimization of Performance Parameters of the TAGGG Telomere Length Assay

Published on: April 21, 2023

3.7K

Related Concept Videos

Cell-surface Signaling01:21

Cell-surface Signaling

54.8K
Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
54.8K
What are Second Messengers?01:12

What are Second Messengers?

90.8K
Because many receptor binding ligands are hydrophilic, they do not cross the cell membrane and thus their message must be relayed to a second messenger on the inside. There are several second messenger pathways, each with their own way of relaying information. G-protein coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol path is active when the receptor induces phospholipase C to hydrolyze the phospholipid,...
90.8K

Articles linked to this work by shared authors, journal, and citation graph.

Membrane Interaction Characteristics of the RTX Toxins and the Cholesterol-Dependence of Their Cytolytic/Cytotoxic Activity.

International journal of molecular sciences·2024

Four Cholesterol-Recognition Motifs in the Pore-Forming and Translocation Domains of Adenylate Cyclase Toxin Are Essential for Invasion of Eukaryotic Cells and Lysis of Erythrocytes.

International journal of molecular sciences·2022

Cholesterol stimulates the lytic activity of Adenylate Cyclase Toxin on lipid membranes by promoting toxin oligomerization and formation of pores with a greater effective size.

The FEBS journal·2021

Irreversible versus repairable membrane poration: differences in permeabilization elicited by Bordetella Adenylate Cyclase Toxin and its hemolysin domain in macrophages.

The FEBS journal·2019

Membrane Permeabilization by Pore-Forming RTX Toxins: What Kind of Lesions Do These Toxins Form?

Toxins·2019

Characterization of the Intrinsic Phospholipase A1 Activity of Bordetella pertussis Adenylate Cyclase Toxin.

Toxins·2018

The genomic origins and evolutionary path to a key innovation in the world's most venomous snakes.

Proceedings of the National Academy of Sciences of the United States of America·2026

One mechanism, two diseases: Involvement of enzyme-substrate complexes in the pathogenesis of celiac disease and rheumatoid arthritis.

Proceedings of the National Academy of Sciences of the United States of America·2026

Peptides adopt stable omega-loop structures in concentrated sulfuric acid.

Proceedings of the National Academy of Sciences of the United States of America·2026

Systematic discovery of circular permutations across the protein universe using CIRPIN.

Proceedings of the National Academy of Sciences of the United States of America·2026

State-sponsored agenda setting: Measuring the impact of narrative laundering.

Proceedings of the National Academy of Sciences of the United States of America·2026

Disentangling unique site-specific and shared habitat-level adaptation in a classic system of repeated evolution.

Proceedings of the National Academy of Sciences of the United States of America·2026

Adoptive MAIT cell therapy for liver cancer enhanced by multimodal modulation of immune receptors and checkpoints.

Med (New York, N.Y.)·2026

Large Deep Temporal Lipomatous Mass Mimicking Liposarcoma on MRI: A Brief Clinical Report.

The Journal of craniofacial surgery·2026

Autosomal recessive MALTA syndrome with compound heterozygous MYH9 variants: Structural modeling reveals disrupted myosin-9 assembly.

JID innovations : skin science from molecules to population health·2026

Associations between deep learning-derived infrapatellar fat pad volume on MRI with knee cartilage thickness and imaging features of knee osteoarthritis: Data from the Osteoarthritis Initiative.

Osteoarthritis and cartilage·2026

Vibration-Controlled Transient Elastography-Based Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease in Saudi Arabia: A Prospective Cohort Study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026

Translation, Cross-Cultural Adaptation, and Validation of the Malay Version of the Roland-Morris Disability Questionnaire for Low Back Pain.

Annals of rehabilitation medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us